Hepatitis C: An In-Depth Guide

Nunavut

Prescription Drug Programs in Nunavut

General information on drug coverage and benefit programs offered by the provincial, territorial and federal governments can be found here.

Coverage for Hepatitis C Medications

In Nunavut, the Non-Insured Health Benefits (NIHB) formulary outlines hepatitis C medications that are eligible for coverage.

Some jurisdictions have or are planning to remove restrictions on who qualifies for treatment coverage. Other jurisdictions have restrictions on who qualifies for treatment coverage. This may include requiring a certain level of liver injury (fibrosis stage). However, often a person can receive treatment coverage if they are experiencing hepatitis C-related health issues, are of child bearing age and are planning to get pregnant within the next 12 months, or are experiencing other health issues specified in the restrictions.

Hepatitis C medications may require special authorization before they can be covered.

What about coverage under the Non-Insured Health Benefits program?

Registered First Nations and recognized Inuit people may be able to access coverage for their hepatitis C medications through the Non-Insured Health Benefits (NIHB).

For more information about NIHB, people can either visit their website or contact them by phone or mail at:

NIHB Northwest Territories and Nunavut Office
Non-Insured Health Benefits
First Nations and Inuit Health
Health Canada
2720 Riverside Drive
Address Locator: 6604C
Ottawa, Ontario
K1A 0K9

Toll-free: 1-888-332-9222

To be eligible to receive health benefits from NIHB, people must first be registered with their Land Claims Organization. People can contact their Land Claims Agreement office using the contact information below to request an application form. Once registered, people can notify their service providers that they have recognized status with their Land Claims Organization so that they can receive benefits from NIHB.  

Service providers are encouraged to bill NIHB directly so that clients are not forced to pay directly for any health services or goods they may require. However, if people must pay for a good or service, they can seek reimbursement from NIHB by completing the NIHB Client Reimbursement Request Form and sending it to the NWT and Nunavut NIHB office. The completed request form must be received within one year from the date they paid for the health service.

If a request for reimbursement is denied, NIHB recipients have the right to file an appeal to have the decision reviewed. More information on the appeals process is available on the NIHB website or by calling the NWT and Nunavut NIHB office.

Land Claims Organizations – Contact Information

Nunavut
Nunavut Tunngavik Incorporated (NTI)
Enrolment Administrator 
Department of Human Resources 
P.O. Box 280 Rankin Inlet, NU X0C 0G0 
Tel: (867) 645-5400
Toll-free: 1-888-236-5400
Fax: (867) 645-3451
Website: www.tunngavik.com

To register, you can also fill out the online application form for the Nunavut Land Claims Agreement (NCLA) and send it to the address above.

 

Costs and Coverage for Treatment in Canada

Some programs can be accessed by all Canadians. Examples include:

Private health insurance

Some health insurance policies offered through private insurance companies include coverage for prescription drugs. These programs often have their own deductible, or co-pay fee, and may have yearly maximums for prescription drugs.

Programs offered by pharmaceutical companies

The pharmaceutical companies that make Hep C medications have programs to help people complete treatment.

These programs have phone support for people on treatment, and part of this support is helping people to access the funding necessary to cover treatment costs. These programs can inform patients about local, provincial, and federal government programs for accessing treatment and can help the patient find out ways to maximize any public funding or private medical insurance (including the appeals process, if the patient also has a supportive doctor). If a person is eligible, some programs can help cover the insurance company co-pay fee, provincial or territorial plan's deductible, and a number of other expenses, depending on a person's specific situation.

AbbVie has the AbbVie Care Program for people taking Holkira Pak (dasabuvir, ombitasvir, paritaprevir and ritonavir) or Maviret (glecaprevir and pibrentasvir). Bristol-Myers Squibb Canada has the CLAIRE Program for people taking Daklinza (daclatasvir). Gilead Sciences has the Momentum HCV Support Program for people taking Epclusa (sofosbuvir and velpatasvir), Harvoni (sofosbuvir and ledipasvir), Sovaldi (sofosbuvir) or Vosevi (sofosbuvir, velpatasvir and voxilaprevir). Janssen has the Janssen BioAdvance Program for people taking Galexos (simeprevir). Merck has the Merck Care Hepatitis Program for people taking Zepatier (elbasvir and grazoprevir).
 

For more information, contact:

 Merck Care Program

 1-866-872-5773

 Momentum Support Program (Gilead)

 1-855-447-7977

 Janssen BioAdvance Program

 bioadvance.ca

AbbVie Care 

1-844-471-2273

CLAIRE Program (Bristol-Myers Squibb Canada)

1-844-HCV-2559

People who contracted hepatitis C from a blood transfusion between 1986 and 1990 may be eligible to have hepatitis C treatment expenses covered by the Hepatitis C January 1, 1986 - July 1, 1990 Class Actions Settlement. To learn more about these programs, see Compensation.

Revised 2018.